HALO vs WY · P/E 15, rev $857.7M vs P/E 43, rev $3.59B
Halozyme Therapeutics Inc (HALO) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
HALO currently screens at market cap $7.10B and trailing P/E 15.3. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the HALO and WY stock pages for the full models.
Not investment advice.